Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Clinical Trials

Discovery & Development Clinical Trials

Why Sex Matters in Drug Development

| Emma Banks | 3 min read

Why conversations on gender in drug development must go further.

Discovery & Development Clinical Trials

Positive Opinion for Regeneron’s Libtayo

| Rob Coker | 3 min read

Regeneron Pharmaceuticals’ Israel Lowy explains how a positive CHMP opinion can become good news for cancer patients

Discovery & Development Drug Discovery

The End of Alopecia?

| Robyn Goforth | 3 min read

Insights into the quest to find an effective treatment for this socially painful condition

Business & Regulation Standards & Regulation

Why Only a Collective Approach Can Beat Fake Medicine

| Géraldine Lissalde-Bonnet | 5 min read

Substandard and falsified medicines are a global threat, but a collective pushback can beat them

Discovery & Development Clinical Trials

Every Disease Has its Day

| Stephanie Sutton | 2 min read

Is now finally the time for Alzheimer’s drug development to shine?

Discovery & Development Clinical Trials

From Viral Video to Magic Medicine

| Angus Stewart | 2 min read

In 2014, the Ice Bucket Challenge raised millions; eight years on, we have an FDA-approved therapy

Business & Regulation Digital Technologies

The Big Question: Can Pharma Truly Be Remodelled with AI?

| Maryam Mahdi | 2 min read

AI’s role in pharma operations and process is growing. But does it have the power to transform the industry?

Manufacture Vaccines

“Could You Patent the Sun?” – Jonas Salk, Albert Sabin, and the Polio Vaccine

| Angus Stewart | 18 min read

How two rival projects relate to a modern disease landscape threatened by climate change and low vaccination rates

Business & Regulation Business Practice

A History of Missed Opportunity

| Maryam Mahdi | 13 min read

What role must pharma play to help improve outcomes for women?

Discovery & Development Clinical Trials

We are the Resensitizers

| Angus Stewart | 8 min read

The cell cycle can be used to shut down cancer’s survival mechanisms, but what does it take to turn that knowledge into a medicine?


Latest White Papers

Accelerate recruitment with a decentralized clinical trial strategy

| Contributed by Thermo Fisher Scientific

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register